Identidade

Alogliptin Impurity C

CAS 1108731-49-2 · C20H23N5O3

01Identidade

Lazychem IDLC-05561
CAS RN1108731-49-2
PubChem CID138454990
Molecular formulaC20H23N5O3
Molecular weight381.44 g/mol
IUPAC name(R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)acetamide
InChIKeyDLPUDCLWEJZQGM-QGZVFWFLSA-N

02Estrutura e estereoquímica

Two-dimensional chemical structure of Alogliptin Impurity C, CAS 1108731-49-2
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count3
Secondary amines0
Tertiary amines1
SMILESCC(=O)N[C@@H]1CCCN(C1)C2=CC(=O)N(C(=O)N2CC3=CC=CC=C3C#N)C
InChINão indicado

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

2 records

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Estado na Índia

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nomes e relações

API e fármaco de origem

Alogliptin

Impurezas e compostos relacionados

Nomes e relações

  • Alogliptin Impurity 15
  • Alogliptin Impurity C
  • 1108731-49-2
  • N-Acetyl alogliptin
  • Alogliptin metabolite m-II
  • UNII-U93RK9Q9H6
  • U93RK9Q9H6
  • Acetamide, N-((3R)-1-(3-((2-cyanophenyl)methyl)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)-3-piperidinyl)-
  • N-((3R)-1-(3-((2-Cyanophenyl)methyl)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)-3-piperidinyl)acetamide
  • N-((3R)-1-(3-((2-Cyanophenyl)methyl)-1-methyl-2,6-dioxo-pyrimidin-4-yl)-3-piperidyl)acetamide
  • N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]acetamide
  • Alogliptin Impurity 3

06Fontes